Skip to content
healthcare.dev

Mycophenolate Mofetil

NDC 16571-282, Mycophenolate Mofetil, powder, for suspension, from Rising Pharma Holdings, Inc..

Product NDC
16571-282
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213955
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-282 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MYCOPHENOLATE MOFETIL200 mg/mL

Pharmacologic classes

Antimetabolite Immunosuppressant [EPC]

Package NDCNDC-11Package
16571-282-17165710282171 BOTTLE, PLASTIC in 1 CARTON (16571-282-17) / 225 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bbe03c1d-02ca-4d39-ace6-6f47e916d5b7

Use it

Look up 16571-282 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-282 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-282. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.